✦ LIBER ✦

Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis

✍ Scribed by Kwong-Ming Kee; Chuan-Mo Lee; Jing-Houng Wang; Hung-Da Tung; Chi-Sin Changchien; Sheng-Nan Lu; Pei-Wen Wang

Book ID: 108950631
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 89 KB
Volume: 21
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2006.03947.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thyroid dysfunction in a UK hepatitis C

Thyroid dysfunction in a UK hepatitis C population treated with interferon-α and ribavirin combination therapy

✍ Seán J. Costelloe; Nancy Wassef; Josephine Schulz; Tina Vaghijiani; Catherine Mo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

The role of thyroid autoantibodies in th

The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy

✍ J-F. Huang; W-L. Chuang; C-Y. Dai; S-C. Chen; Z-Y. Lin; L-P. Lee; P-L. Lee; L-Y. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Effect of lactoferrin in patients with c

Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin

✍ Masahiko Kaito; Motoh Iwasa; Naoki Fujita; Yoshinao Kobayashi; Yuji Kojima; Jiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

A fatal case of phlegmonous colitis in c

A fatal case of phlegmonous colitis in chronic hepatitis C receiving combination interferon and ribavirin therapy

✍ S. H. Pang; K. De Silva; J. Napoli; B. E. Jones 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a